Dr. Shicha Kumar, MD

Dr. Kumar practices at Robert Wood Johnson University Hospital in New Brunswick, New Jersey, part of RWJBarnabas Health.

Dr. Kumar's NPI, 1518100262, was assigned on April 10, 2009. Dr. Kumar holds New Jersey license 25MA09875800.

Dr. Kumar's primary practice is Robert Wood Johnson University Hospital, at One Robert Wood Johnson Place, New Brunswick, NJ 08901 in Middlesex County. The practice phone is (732) 828-3000. Dr. Kumar also practices at Robert Wood Johnson University Hospital - New Brunswick, 1 Robert Wood Johnson Pl, New Brunswick, NJ 08901.

Dr. Kumar's primary practice is Robert Wood Johnson University Hospital in New Brunswick, New Jersey, part of RWJBarnabas Health. Dr. Kumar is also affiliated with Robert Wood Johnson University Hospital Somerset. The medical group on file is Rutgers-RWJ Scleroderma Program. Dmand AI also links Dr. Kumar to 1 more hospital and 1 group practice or clinic, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Kumar practices, 4 sites in all. Vendor and product names are available with a free account.

Surgery is Dr. Kumar's primary specialty in the NPI Registry, under taxonomy code 208600000X. Dmand AI has Dr. Kumar's licenses on file in 2 states: New Jersey and New York.

CMS data shows 156 Medicare services from Dr. Kumar across 6 procedure codes in 2024, for 86 Medicare patients. Medicare paid $24,155 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 86 Medicare patients who saw Dr. Kumar in 2024. The largest group is 65 to 74, with 40 patients. 75% of them have cancer, and 75% have high blood pressure. 21% are also on Medicaid. Their average risk score is 1.15, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Dr. Kumar's median patient age at 59, with 96% women.

In 2024, Dr. Kumar wrote 26 Medicare Part D claims for 20 patients. 100% of them were for generic drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 88 out of 100 for Dr. Kumar for performance year 2024, reported as part of a group. Dr. Kumar accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Kumar as offering telehealth. CMS counts 14 procedures of mastectomy by Dr. Kumar, more than 70% of the clinicians it reports for that procedure.

Melanoma (skin cancer) excision: 1 to 10 procedures (CMS shows small counts as a range)

Skin biopsy: 1 to 10 procedures (CMS shows small counts as a range)

Dmand AI links 31 papers to Dr. Kumar, published from 2013 to 2024. 2022 was the busiest year, with 6. The most frequent topics are Breast Neoplasms, Mastectomy and Mastectomy, Segmental. Dr. Kumar has published most often in Clin Breast Cancer. Dr. Kumar's most frequent co-authors are Bruce G. Haffty, MD, Nisha Ohri, MD and Mridula A. George.

Dmand AI links Dr. Kumar to 1 clinical trial. Conditions studied include Breast Neoplasms and Breast Diseases.

CMS Open Payments shows 11 general payments to Dr. Kumar from 5 drug and device companies from 2016 to 2024. Speaker and faculty fees make up the largest share, 74% of the total. Daiichi Sankyo Inc. paid the most, $5,201.